A partnership opportunity for Australia · September 2026
An opportunity to support a major maternal health initiative: giving Australian women access to pregnancy and breastfeeding support, while helping establish an independently governed research program that measures what actually happens to them over time.
For a partner, it is a chance to stand beside Australian families when it matters most, with results you can measure.

The problem
The distance between those two numbers has a name: the Intention Gap. It is not a matter of choice. It is a matter of preparation, support, and when that support arrives.
Australia's only dedicated national infant feeding survey was run in 2010, and it has never been repeated. In 2026, a review of 55 studies found that not one had made the Intention Gap its main outcome. Next 10,000 does.
For a partner, this is the gap your support helps close.
Sources: 2010 Australian National Infant Feeding Survey. Saito et al., BMC Pregnancy and Childbirth, 2026.
The shift
In 2019, every Australian health minister endorsed a national goal: half of all babies exclusively breastfed to around six months by 2025. That deadline has passed. No national survey has measured whether it was reached, and every current estimate sits well below it.
Around the world, the momentum is building. In September 2026, Olivia and Tom Walton committed an initial US$100 million to halve maternal deaths in the United States. Health systems, insurers and employers are moving in the same direction.
The research has set out what good support looks like: continuous, connected care that does not reset between pregnancy, hospital, home and the return to work.
The specification is written, and we already run it. What is missing is the evidence at scale, and that is what Next 10,000 produces.
For a partner, this is the chance to be early: backing the evidence before it becomes the standard.
The opportunity
The Australian cohort: ten thousand pregnant Australian women, one of three cohorts alongside the United Kingdom and the United States. Each woman is prepared before birth with The Thompson Method and supported daily through My Milk Map. Within that program, women who choose to take part form an implementation study, run under independent human research ethics approval. Women in the study take part at no cost.
Each woman is measured against her own stated intention rather than against other mothers, and followed for twelve months from birth. The result is a full year of prospective maternal and infant health data of a kind that does not currently exist in Australia.
No woman will be enrolled in the research until ethics approval is granted.
For a partner, it means your name attached to evidence nobody else in Australia has.

Why us
Dr Robyn Thompson PhD OAM, 1944 to 2025.
We are not starting from scratch. The Thompson Method began with Dr Robyn Thompson's PhD on nipple trauma, continued through the research program at Mater Mothers' Hospital in Brisbane from which the method developed, and has been published twice: in Women and Birth in 2016, and independently by Allen and colleagues in the International Journal of Nursing Studies in 2023, across 13,667 mother and baby pairs. Professor Sue Kildea is a co-author across that body of work.
Then we took it to the world. One hundred thousand women over eight years, with the support model rebuilt each year around what those women said they needed. My Milk Map is the result.
The method is published. The delivery is trusted by 100,000 women. What has never been done is running both together, at scale, and measuring it properly.
For a partner, that means backing a method with fifty years behind it, not an experiment.
The film
Most research ends in a journal. The findings of Next 10,000 will go to governments, health systems and hospital policy makers, to change how women are supported before and after birth. That work matters, but it can be a slow process.
This research has something most research rarely gets: a feature documentary. WHAT THEY KNOW tells the story of Dr Robyn Thompson's life's work, narrated by a two-time Academy Award winner (name withheld) and currently in development.
The film turns percentages into people. The Intention Gap stops being a statistic and becomes a woman who planned to feed her baby, and what changed when she was prepared before birth. The film carries what is already proven. The study produces what is still missing. Together they reach the women who need it now, while we sit at the table with policy makers.
Research builds the case institutions can fund and adopt. The film builds the culture that makes adoption possible.
The draft treatment for WHAT THEY KNOW. WHAT THEY KNOW is a working title.
As a sponsor, you will be acknowledged in the film's credits as a backer of the Next 10,000 research. Separate partnership opportunities connected to the film will be shared as the production takes shape. No partnership, at any level, carries creative control over the film.
For a partner, it means research that reaches the public, not just a journal.
The fit
One partnership, two returns. A reputation nobody else can buy: backing the research that proves prevention works. And a customer return you can measure, through an activation program we run with our community.
Reaching pregnant women through advertising is getting harder. Our community already trusts us, and they are with us every day.
Families think hardest about their cover around having a baby. The earliest and cheapest prevention window in a member's life starts before birth, and almost nobody is covering it. Backing Next 10,000 puts your fund at the start of that story, and the activation brings families to you at the moment they are choosing.
One-day absences to care for a sick child happen more than twice as often when infants are not breastfed, a finding cited by the US CDC. The first year back is also when experienced women quietly leave. Backing Next 10,000 builds the evidence for keeping them, and My Milk Map is a program your people can use directly as a benefit.
Pregnant women and new mothers already shop with you, week in, week out. They are being sold to in a category where almost nobody is supporting them. This is not an audience to acquire, it is one to serve, and the activation turns that trust into measurable new customers.
Your customers are these mothers, at the moment trust is formed. Backing independent evidence places your brand alongside the support she remembers, not the advertising she scrolls past.
The Research Partner package
A$1M funds one full cohort of 10,000 women: around A$100 for each woman, prepared through the program and, if she chooses to take part, measured in the study.
Partners can fund a full cohort, or join with others to fund one together.
A monthly program, designed with you and run by us through our wider community, so your partnership reaches the women and families who matter to you.
Activation can begin in the first month, while the research moves through ethics approval. It is tailored to each partner.
Kept separate, by design. Women taking part in the research are never included in partner activation, and everything we feature meets The Thompson Method's clinical standards.

What a partner receives
Named acknowledgement on the project platform and in project communications, as a supporter of independent maternal health research.
Aggregate reporting on the reach and impact your support enabled: how many women, where, and what changed for them.
Support that goes directly to women who would not otherwise receive the program.
Your name alongside a prospective cohort built around the question no study has yet made its main outcome: the Intention Gap.
The opportunity to communicate the partnership through your own health, wellbeing and community channels.
Briefings on research findings as they become available, while remaining independent from the scientific process.
Credited in WHAT THEY KNOW as a backer of the Next 10,000 research.
KPIs agreed before we start, tracked through your own codes and links, and reported every month.
Your partnership in front of pregnant women and new families, alongside the support they already rely on.
The reassurance
Commercial funding of research is common and, provided it is transparent and appropriately managed, does not in itself stand in the way of ethics approval. The principles are straightforward: the funding relationship is disclosed, and the funder does not control the study design, the analysis, the interpretation, or the publication of results.
Built in from the start, because we have a commercial interest in the result and the Index will be making public arguments about data quality:
The same separation applies to the film. Sponsors are credited as backers of the research, never given a say in the story.
A partner can be recognised as a funder without controlling what the research finds or how it is reported. That separation is what makes the recognition worth having.
Not a fixed proposal. We would like to understand whether this is the kind of initiative you would want to be part of, how many women you would want to bring in, and what a successful activation would look like for you. We can build the right partnership around that.
Joanne Thompson
Co-founder and CEO, The Thompson Method Group
+61 419 315 948 · LinkedIn